Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 307,079 | 170,068 | 76,823 | 281,594 | 196,206 |
| Depreciation Amortization | 57,883 | 38,803 | 19,671 | 85,841 | 65,809 |
| Income taxes - deferred | 15,824 | 15,532 | 1,291 | 34,506 | 25,083 |
| Accounts receivable | -51,533 | 19,687 | 38,308 | -3,339 | 13,546 |
| Other Working Capital | -114,646 | -60,707 | 21,555 | -38,671 | -15,154 |
| Other Operating Activity | 85,990 | 1,838 | -28,221 | 28,640 | 727 |
| Operating Cash Flow | $300,597 | $185,221 | $129,427 | $388,571 | $286,217 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -596,157 | -118,593 | -79,136 | -81,615 | -271,617 |
| PPE Investments | 303,954 | -6,127 | -3,545 | -15,294 | 182,999 |
| Investing Cash Flow | $-292,203 | $-124,720 | $-82,681 | $-96,909 | $-88,618 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -489 | -13,483 | -13,483 |
| Common Stock Issued | 27,554 | 8,993 | N/A | 7,879 | 5,499 |
| Common Stock Repurchased | N/A | N/A | N/A | -402,383 | -150,083 |
| Financing Cash Flow | $27,554 | $8,993 | $-489 | $-407,987 | $-158,067 |
| Beginning Cash Position | 118,370 | 118,370 | 118,370 | 234,695 | 234,695 |
| End Cash Position | 154,318 | 187,864 | 164,627 | 118,370 | 274,227 |
| Net Cash Flow | $35,948 | $69,494 | $46,257 | $-116,325 | $39,532 |
| Free Cash Flow | |||||
| Operating Cash Flow | 300,597 | 185,221 | 129,427 | 388,571 | 286,217 |
| Capital Expenditure | -7,644 | -6,127 | -3,545 | -15,294 | -12,698 |
| Free Cash Flow | 292,953 | 179,094 | 125,882 | 373,277 | 273,519 |